Allogene Therapeutics Inc Shares Close the Week 21.2% Lower - Weekly Wrap
The company saw its shares close the week 21.2% lower than last week, with trading volume higher than its 30 day average.
May 13, 2022 by Kwhen Finance Editors
Allogene Therapeutics Inc (ALLO) shares closed this week 21.2% lower than it did at the end of last week. The stock is currently down 51.5% year-to-date, down 73.7% over the past 12 months, and down 71.1% over the past five years. This week, the Dow Jones Industrial Average fell 2.1%, and the S&P 500 fell 2.3%.
Trading Activity
- Shares traded as high as $8.97 and as low as $6.42 this week.
- Shares closed 77.2% below its 52-week high and 12.4% above its 52-week low.
- Trading volume this week was 18.5% higher than the 10-day average and 42.2% higher than the 30-day average.
- Beta, a measure of the stock’s volatility relative to the overall market stands at 1.8.
Technical Indicators
- The Relative Strength Index (RSI) on the stock was between 30 and 70.
- MACD, a trend-following momentum indicator, indicates a downward trend.
- The stock closed below its Bollinger band, indicating it may be oversold.
Market Comparative Performance
- The company's share price lags the S&P 500 Index this week, lags it on a 1-year basis, and lags it on a 5-year basis
- The company's share price lags the Dow Jones Industrial Average this week, lags it on a 1-year basis, and lags it on a 5-year basis
- The company share price lags the performance of its peers in the Health Care industry sector this week, lags it on a 1-year basis, and lags it on a 5 year basis
| Name | DoD %Δ | YTD %Δ | 1 Yr % | 52-Week H % | 52-Week L % |
|---|---|---|---|---|---|
| Allogene Therapeutics Inc | 3.7 | -51.5 | -73.7 | -77.7 | 10.4 |
| Dow Jones Industrial Average | 1.4 | -10.9 | -3.7 | -12.9 | 2.5 |
| S&P 500 Index | 2.4 | -15.2 | -0.8 | -17.1 | 3.0 |
| Health Care | 1.3 | -10.5 | 2.3 | -11.7 | 3.6 |
Peer Group Comparative Performance
- The company's stock price performance year-to-date lags the peer average by 97.0%
- The company's stock price performance over the past 12 months lags the peer average by 171.5%
| Name | MKT CAP (USD) | P/E | YTD %Δ | 1 Yr %Δ | 52-Week H % | 52-Week L % |
|---|---|---|---|---|---|---|
| Allogene Therapeutics Inc | ALLO | 0 | -51.5 | -73.7 | -77.7 | 10.4 |
| Peer Avg | N/A | 0 | -26.2 | -27.2 | -31.9 | 4.1 |
| Ovid Therapeutics Inc | OVID | 0 | -31.8 | -38.8 | -52.3 | 5.0 |
| Oyster Point Pharma Inc | OYST | 0 | -72.9 | -69.8 | -75.2 | 11.3 |
This story was produced by the Kwhen Automated News Generator. For more articles like this, please visit us at finance.kwhen.com. Write to editors@kwhen.com. © 2021 Kwhen Inc.
Was this content valuable for you?
Tags: